Immunomedics, Inc. (NQ:IMMU)
Delayed: 3.14 --0 (-0%)
Trade Now!
Previous Close $3.14    52 Week High $3.76 
Open $3.13    52 Week Low $2.11 
Day High $3.17    P/E N/A 
Day Low $3.10    EPS $-0.16 
Volume 3,013,615       


May 8, 2013 04:54 PM Immunomedics, Inc. (IMMU) Swings to Q3 Profit
May 8, 2013 04:23 PM Form 10-Q IMMUNOMEDICS INC For: Mar 31
May 8, 2013 04:01 PM Form 8-K IMMUNOMEDICS INC For: May 08
May 8, 2013 04:00 PM Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program Developments
May 7, 2013 08:30 AM Immunomedics Announces Three New Patent Awards
Apr 25, 2013 08:30 AM Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial Results
Apr 10, 2013 08:32 AM Immunomedics (IMMU) Updates on Preclinical Data for T-cell Redirecting Agent Development
Apr 10, 2013 08:30 AM Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors
Apr 9, 2013 08:30 AM Immunomedics Reports First Results of Labetuzumab-SN-38 in Colorectal Cancer
Apr 8, 2013 04:30 PM Immunomedics Creates Novel Antibody-Cytokine Conjugates for Cancer Therapy
View All Articles

Entities mentioned with IMMU

View All Entities